Martin Uhl

Franz Josef Strauss Allee 11
Regensburg, BY 93053, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

The course of tumor-related epilepsy in glioblastoma patients: A retrospective analysis.

The course of tumor-related epilepsy in glioblastoma patients: A retrospective analysis.

Journal: Epilepsy & behavior : E&B

Published: February 05, 2024

Case report: Cerebrospinal fluid neutrophilic pleocytosis upon intrathecal triamcinolone injection.

Case report: Cerebrospinal fluid neutrophilic pleocytosis upon intrathecal triamcinolone injection.

Journal: Frontiers in neurology

Published: January 17, 2024

Status epilepticus in patients with glioblastoma: Clinical characteristics, risk factors, and epileptological outcome.

Status epilepticus in patients with glioblastoma: Clinical characteristics, risk factors, and epileptological outcome.

Journal: Seizure

Published: June 12, 2023

Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin.

Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin.

Journal: International journal of molecular sciences

Published: July 29, 2022

Cetuximab-Induced Aseptic Meningitis in a Patient with Colorectal Cancer: A Case Report and Review of Literature.

Cetuximab-Induced Aseptic Meningitis in a Patient with Colorectal Cancer: A Case Report and Review of Literature.

Journal: Case reports in neurology

Published: May 11, 2022

Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.

Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.

Journal: The Lancet. Oncology

Published: April 19, 2019

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.

Journal: Lancet (London, England)

Published: April 26, 2018

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.

Journal: Neuro-oncology

Published: November 10, 2017

A Case Report of Severe Delirium after Amantadine Withdrawal.

A Case Report of Severe Delirium after Amantadine Withdrawal.

Journal: Case reports in neurology

Published: November 10, 2016

Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials.

Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials.

Journal: Journal of neuro-oncology

Published: September 20, 2016

Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.

Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.

Journal: Cell cycle (Georgetown, Tex.)

Published: May 11, 2016

Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature.

Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature.

Journal: Frontiers in oncology

Published: April 17, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026